LYELL IMMUNOPHARMA INC (LYEL): Institutional Ownership
Hedge funds and institutional managers reporting a position in LYEL · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
8
13F filers
Aggregate Value
$14.1M
Across holders
Last Price
$11.61
2026-06-26
Sector
Health Care
GICS
Holder activity3 new4 added1 reduced
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 381K | $7.7M | 54.4% | 0.0% | Added | +$7.3M | Q1 2026 |
| RENAISSANCE TECHNOLOGIES LLC CIK 0001037389 | Hedge Fund | 116K | $2.3M | 16.6% | 0.0% | Added | +$1.5M | Q1 2026 |
| MARSHALL WACE, LLP CIK 0001318757 | Hedge Fund | 88K | $1.8M | 12.6% | 0.0% | Added | +$758K | Q1 2026 |
| Qube Research & Technologies Ltd CIK 0001729829 | Hedge Fund | 55K | $1.1M | 7.9% | 0.0% | Added | +$924K | Q1 2026 |
| Walleye Capital LLC CIK 0001758720 | Hedge Fund | 22K | $445K | 3.2% | 0.0% | New | — | Q1 2026 |
| Brevan Howard Capital Management LP CIK 0001512857 | Hedge Fund | 13K | $270K | 1.9% | 0.0% | New | — | Q1 2026 |
| ExodusPoint Capital Management, LP CIK 0001736225 | Hedge Fund | 9K | $262K | 1.9% | 0.0% | New | — | Q4 2025 |
| TWO SIGMA INVESTMENTS, LP CIK 0001179392 | Hedge Fund | 12K | $232K | 1.7% | 0.0% | Reduced | $-81K | Q1 2026 |
Added
Hedge Fund
$7.7M· 54.4% of total· 0.0% port· 381K sh· +$7.3M QoQ· Q1 2026
Added
Hedge Fund
$2.3M· 16.6% of total· 0.0% port· 116K sh· +$1.5M QoQ· Q1 2026
Added
Hedge Fund
$1.8M· 12.6% of total· 0.0% port· 88K sh· +$758K QoQ· Q1 2026
Added
Hedge Fund
$1.1M· 7.9% of total· 0.0% port· 55K sh· +$924K QoQ· Q1 2026
New
Hedge Fund
$445K· 3.2% of total· 0.0% port· 22K sh· — QoQ· Q1 2026
New
Hedge Fund
$270K· 1.9% of total· 0.0% port· 13K sh· — QoQ· Q1 2026
New
Hedge Fund
$262K· 1.9% of total· 0.0% port· 9K sh· — QoQ· Q4 2025
Reduced
Hedge Fund
$232K· 1.7% of total· 0.0% port· 12K sh· $-81K QoQ· Q1 2026